A mission to make prescribed care as effective as possible
We are a design-led health technology company, working to help patients self-manage their conditions and improve the relationship they have with healthcare systems.
Our values
Patient-centred
Our duty of care, above everything else, is to the people who are living with chronic conditions and using our products to manage their health. Our work is designed to empower them and help them achieve better outcomes. We design for the patient first, clinicians a close second.
Long-term view
We are not interested in short-termism. No shortcuts, no quick wins. Using our products means inviting a new technology into your life. That relationship, and the validity of the insights for patients and clinicians, is built on enduring trust. We don’t take this role for granted.
Evidence-based, not evidence-bound
We want our impact to be demonstrable. That said, digital health is new in the lifetime of medicine, and things move quickly. We are willing to challenge accepted thinking and research and put significant effort into proving or disproving the value of our work.
High standards, high humility
Our goal is to set the absolute highest standards in experience design for digital health. This translates into every interaction of our company, large or small. To achieve that, there is a lot we need to learn, and we don’t assume to already know the right answers.
Our history
2021
Company formed
Work begins on novel conversational AI platform.
2022
First patient testing
Patients with asthma and type 2 diabetes use Aide at Pickering Medical Practice.
£1.2m pre-seed
Round led by Salica Investments with Fuel Ventures and Heartfelt.
2023
Hypertension added
NIHR funding leads to our third supported condition.
NHS accelerator
Aide Health is selected to join the prestigious healthtech accelerator.
2x Gold at BIMA
Aide wins top honours in Health and Wellness and Digital Products.
2024
First national news coverage
Outcomes from our work with Suffolk Primary Care are published in The iPaper.
AI for Health
Aide Health is selected for the Google for Startups: AI for Health programme.
Class I UK Medical Device
A significant regulatory milestone for our digital chronic condition platform, Aide.
2025
Major UK footprint expansion
Aide is now serving the NHS in London, the North East, North West and East of England.
ABHI US Accelerator
Aide Health joins four trade missions to the US with the ABHI.
Blood cancers
Aide Health awarded £700k funding to develop a pathway for blood cancers.
Six conditions supported
Aide adds pathways for COPD, chronic kidney disease and obesity.
Launch of Mirror
The first medical AI note-taker for patients is launched in the UK.
Aide Health is backed by some of the leading UK and European venture capital funds, alongside prominent angel investors in the UK and US.
Work with us
All of our design and technology is developed internally. If you want to create digital health products that define the modern transformation of healthcare, we want to hear from you.